NMDA receptor antagonism potentiates the l-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats

Neuropharmacology

Volumn 85, Issue , 2014, Pages 198-205

  El Arfani, Anissa ^a   Bentea, Eduard ^a   Aourz, Najat ^a   Ampe, Ben ^a   De Deurwaerdère, Philippe ^b   Van Eeckhaut, Ann ^a   Massie, Ann ^a   Sarre, Sophie ^a   Smolders, Ilse ^a   Michotte, Yvette ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

6 OHDA rat model; Dopamine; In vivo microdialysis; l DOPA; NMDA receptor antagonist; Subthalamic nucleus

Indexed keywords

DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXIDOPAMINE; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIPARKINSON AGENT; DIZOCILPINE MALEATE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN LEVEL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; EXTRACELLULAR SPACE; IN VIVO STUDY; MALE; MICRODIALYSIS; MOLECULAR DYNAMICS; MONOTHERAPY; NERVE DEGENERATION; NONHUMAN; OUTCOME ASSESSMENT; PARKINSONISM; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBTHALAMIC NUCLEUS; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; HEMISPHERIC DOMINANCE; METABOLISM; PARKINSONIAN DISORDERS; PATHOPHYSIOLOGY; SUBSTANTIA NIGRA; WISTAR RAT;

ANIMALS; ANTIPARKINSON AGENTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; FUNCTIONAL LATERALITY; GLUTAMIC ACID; LEVODOPA; MALE; MICRODIALYSIS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 84902291791     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.05.024     Document Type: Article

References (76)

1. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
2. K.A. Allers, D.A. Bergstrom, L.J. Ghazi, D.S. Kreiss, and J.R. Walters MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease Exp. Neurol. 191 2005 104 118
3. B. Ampe, A. Massie, J. D'Haens, G. Ebinger, Y. Michotte, and S. Sarre NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats J. Neurochem. 103 2007 1063 1074
4. D. Apetauerova, R.K. Ryan, S.I. Ro, J. Arle, J. Shils, E. Papavassiliou, and D. Tarsy End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation Mov. Disord. 21 2006 1277 1279
5. T.Z. Aziz, D. Peggs, M.A. Sambrook, and A.R. Crossman Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced parkinsonism in the primate Mov. Disord. 6 1991 288 292
6. A.L. Benabid, P. Pollak, C. Gross, D. Hoffmann, A. Benazzouz, D.M. Gao, A. Laurent, M. Gentil, and J. Perret Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease Stereotact. Funct. Neurosurg. 62 1994 76 84
7. A. Benazzouz, C. Gross, J. Féger, T. Boraud, and B. Bioulac Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys Eur. J. Neurosci. 5 1993 382 389
8. H. Bergman, T. Wichmann, and M.R. DeLong Reversal of experimental parkinsonism by lesions of the subthalamic nucleus Science 249 1990 1436 1438
9. H. Bergman, T. Wichmann, B. Karmon, and M.R. DeLong The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism J. Neurophysiol. 72 1994 507 520
10. F. Bibbiani, J.D. Oh, A. Kielaite, M.A. Collins, C. Smith, and T.N. Chase Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD Exp. Neurol. 196 2005 422 429
11. F. Blandini, M. Garcia-Osuna, and J.T. Greenamyre Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats Eur. J. Neurosci. 9 1997 1407 1413
12. F. Blandini, J.T. Greenamyre, R. Fancellu, and G. Nappi Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions Neurol. Sci. 22 2001 49 50
13. F. Blandini, G. Nappi, C. Tassorelli, and E. Martignoni Functional changes of the basal ganglia circuitry in Parkinson's disease Prog. Neurobiol. 62 2000 63 88
14. S. Breit, R. Bouali-Benazzouz, A.L. Benabid, and A. Benazzouz Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat Eur. J. Neurosci. 14 2001 1833 1842
15. F. Calon, M. Morissette, O. Ghribi, M. Goulet, R. Grondin, P.J. Blanchet, P.J. Bédard, and T. Di Paolo Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 127 138
16. F. Calon, A.H. Rajput, O. Hornykiewicz, P.J. Bédard, and T. Di Paolo Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease Neurobiol. Dis. 14 2003 404 416
17. G.A. Campbell, M.J. Eckardt, and F.F. Weight Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis Brain Res. 333 1985 261 270
18. N.S. Canteras, S.J. Shammah-Lagnado, B.A. Silva, and J.A. Ricardo Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat Brain Res. 513 1990 43 59
19. M. Carta, T. Carlsson, D. Kirik, and A. Björklund Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 130 2007 1819 1833
20. R. Cilia, G. Marotta, A. Landi, I.U. Isaias, C.B. Mariani, F. Vergani, R. Benti, E. Sganzerla, G. Pezzoli, and A. Antonini Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study Clin. Neurol. Neurosurg. 111 2009 140 146
21. P. Del Dotto, N. Pavese, G. Gambaccini, S. Bernardini, L.V. Metman, T.N. Chase, and U. Bonuccelli Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study Mov. Disord. 16 2001 515 520
22. M.R. DeLong Primate models of movement disorders of basal ganglia origin Trends Neurosci. 13 1990 281 285
23. A.D. Dorval, and W.M. Grill Deep brain stimulation of the subthalamic nucleus reestablishes neuronal information transmission in the 6-OHDA rat model of parkinsonism J. Neurophysiol. 111 2014 1949 1959
24. A.W. Dunah, Y. Wang, R.P. Yasuda, K. Kameyama, R.L. Huganir, B.B. Wolfe, and D.G. Standaert Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease Mol. Pharmacol. 57 2000 342 352
25. T.M. Engber, J.J. Anderson, R.C. Boldry, S.M. Papa, S. Kuo, and T.N. Chase Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats Neuroscience 59 1994 389 399
26. T.M. Engber, S.M. Papa, R.C. Boldry, and T.N. Chase NMDA receptor blockade reverses motor response alterations induced by levodopa Neuroreport 5 1994 2586 2588
27. A. Fisher, C.S. Biggs, and M.S. Starr Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat Brain Res. 792 1998 126 132
28. A. Fitoussi, F. Dellu-Hagedorn, and P. De Deurwaerdère Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition Neuroscience 255 2013 233 245
29. J. Féger, M. Bevan, and A.R. Crossman The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labelling study Neuroscience 60 1994 125 132
30. A. Galvan, A. Charara, J.F. Pare, A.I. Levey, and Y. Smith Differential subcellular and subsynaptic distribution of GABA(A) and GABA(B) receptors in the monkey subthalamic nucleus Neuroscience 127 2004 709 721
31. J.T. Greenamyre, R.V. Eller, Z. Zhang, A. Ovadia, R. Kurlan, and D.M. Gash Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease Ann. Neurol. 35 1994 655 661
32. J.T. Greenamyre, and C.F. O'Brien N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease Arch. Neurol. 48 1991 977 981
33. P. Gubellini, P. Salin, L. Kerkerian-Le Goff, and C. Baunez Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior Prog. Neurobiol. 89 2009 79 123
34. O.K. Hassani, C. François, J. Yelnik, and J. Féger Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat Brain Res. 749 1997 88 94
35. P. Izurieta-Sánchez, S. Sarre, G. Ebinger, and Y. Michotte Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats Eur. J. Pharmacol. 353 1998 33 42
36. N. Jonkers, S. Sarre, G. Ebinger, and Y. Michotte MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats Eur. J. Pharmacol. 407 2000 281 291
37. N. Jonkers, S. Sarre, G. Ebinger, and Y. Michotte MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats Brain Res. 926 2002 149 155
38. T. Klockgether, and L. Turski NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats Ann. Neurol. 28 1990 539 546
39. D.S. Kreiss, C.W. Mastropietro, S.S. Rawji, and J.R. Walters The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease J. Neurosci. 17 1997 6807 6819
40. J.F.R. König, and R.A. Klippel The Rat Brain - a Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem 1963 Robert E Krieger Publishing New York
41. F. Lejeune, A. Gobert, J.M. Rivet, and M.J. Millan Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones Brain Res. 656 1994 427 431
42. R. Levy, L.N. Hazrati, M.T. Herrero, M. Vila, O.K. Hassani, M. Mouroux, M. Ruberg, H. Asensi, Y. Agid, J. Féger, J.A. Obeso, A. Parent, and E.C. Hirsch Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states Neuroscience 76 1997 335 343
43. P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.L. Benabid Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease N Engl. J. Med. 339 1998 1105 1111
44. P. Limousin, P. Pollak, A. Benazzouz, D. Hoffmann, J.F. Le Bas, E. Broussolle, J.E. Perret, and A.L. Benabid Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation Lancet 345 1995 91 95
45. H.S. Lindgren, D.R. Andersson, S. Lagerkvist, H. Nissbrandt, and M.A. Cenci L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia J. Neurochem. 112 2010 1465 1476
46. M. Lundblad, M. Andersson, C. Winkler, D. Kirik, N. Wierup, and M.A. Cenci Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur. J. Neurosci. 15 2002 120 132
47. P.J. Magill, J.P. Bolam, and M.D. Bevan Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network Neuroscience 106 2001 313 330
48. C. Marin, S. Papa, T.M. Engber, M. Bonastre, E. Tolosa, and T.N. Chase MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats Brain Res. 736 1996 202 205
49. A. Massie, S. Goursaud, A. Schallier, K. Vermoesen, C.K. Meshul, E. Hermans, and Y. Michotte Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats Neurochem. Int. 57 2010 572 578
50. A. Massie, A. Schallier, K. Vermoesen, L. Arckens, and Y. Michotte Biphasic and bilateral changes in striatal VGLUT1 and 2 protein expression in hemi-Parkinson rats Neurochem. Int. 57 2010 111 118
51. C.K. Meshul, N. Emre, C.M. Nakamura, C. Allen, M.K. Donohue, and J.F. Buckman Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion Neuroscience 88 1999 1 16
52. D.W. Miller, and E.D. Abercrombie Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats J. Neurochem. 72 1999 1516 1522
53. I.J. Mitchell, C.E. Clarke, S. Boyce, R.G. Robertson, D. Peggs, M.A. Sambrook, and A.R. Crossman Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neuroscience 32 1989 213 226
54. M. Morelli, S. Fenu, A. Pinna, and G. Di Chiara Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression J. Pharmacol. Exp. Ther. 260 1992 402 408
55. S. Navailles, B. Bioulac, C. Gross, and P. De Deurwaerdère Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease Neurobiol. Dis. 38 2010 136 143
56. S. Navailles, M. Lagière, A. Contini, and P. De Deurwaerdère Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain ACS Chem. Neurosci. 4 2013 680 692
57. J.A. Obeso, M. Rodriguez-Oroz, C. Marin, F. Alonso, I. Zamarbide, J.L. Lanciego, and M. Rodriguez-Diaz The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits Neurology 62 2004 S17 S30
58. J.D. Oh, D.S. Russell, C.L. Vaughan, T.N. Chase, and D. Russell Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration Brain Res. 813 1998 150 159
59. G. Orieux, C. Francois, J. Féger, J. Yelnik, M. Vila, M. Ruberg, Y. Agid, and E.C. Hirsch Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease Neuroscience 97 2000 79 88
60. S.M. Papa, R.C. Boldry, T.M. Engber, A.M. Kask, and T.N. Chase Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade Brain Res. 701 1995 13 18
61. A. Parent, and L.N. Hazrati Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop Brain Res. Brain Res. Rev. 20 1995 91 127
62. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press New York
63. G. Pelled, H. Bergman, and G. Goelman Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study Eur. J. Neurosci. 15 2002 389 394
64. R.H. Porter, J.G. Greene, D.S. Higgins, and J.T. Greenamyre Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion J. Neurosci. 14 1994 7192 7199
65. A. Quintana, V. Sgambato-Faure, and M. Savasta Effects of L-DOPA and STN-HFS dyskinesiogenic treatments on NR2B regulation in basal ganglia in the rat model of Parkinson's disease Neurobiol. Dis. 48 2012 379 390
66. K.S. Rommelfanger, and T. Wichmann Extrastriatal dopaminergic circuits of the basal ganglia Front. Neuroanat. 4 2010 139
67. S. Sarre, M. Lanza, F. Makovec, R. Artusi, G. Caselli, and Y. Michotte In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats Eur. J. Pharmacol. 584 2008 297 305
68. S. Sarre, K. Thorré, I. Smolders, and Y. Michotte Microbore liquid chromatography analysis of monoamine transmitters Methods Mol. Biol. 72 1997 185 196
69. C.C. Smith, and R.W. Greene CNS dopamine transmission mediated by noradrenergic innervation J. Neurosci. 32 2012 6072 6080
70. M.S. Starr Antiparkinsonian actions of glutamate antagonists-alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms J. Neural Transm. Parkinson's Dis. Dement. Sect. 10 1995 141 185
71. C.H. Tai, T. Boraud, E. Bezard, B. Bioulac, C. Gross, and A. Benazzouz Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata FASEB J. 17 2003 1820 1830
72. K.A. Tayarani-Binazir, M.J. Jackson, I. Strang, M. Jairaj, S. Rose, and P. Jenner Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat Behav. Pharmacol. 23 2012 126 133
73. A. Van Hemelrijck, S. Sarre, I. Smolders, and Y. Michotte Determination of amino acids associated with cerebral ischaemia in rat brain microdialysates using narrowbore liquid chromatography and fluorescence detection J. Neurosci. Methods 144 2005 63 71
74. S. Varanese, J. Howard, and A. Di Rocco NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease Mov. Disord. 25 2010 508 510
75. M. Vila, R. Levy, M.T. Herrero, B. Faucheux, J.A. Obeso, Y. Agid, and E.C. Hirsch Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study Neuroscience 71 1996 903 912
76. M. Vila, C. Marin, M. Ruberg, A. Jimenez, R. Raisman-Vozari, Y. Agid, E. Tolosa, and E.C. Hirsch Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia J. Neurochem. 73 1999 344 352